Exoskeleton Use With In Home Functional Activities
Launched by A.T. STILL UNIVERSITY OF HEALTH SCIENCES · Jan 12, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how people with paraplegia can use exoskeletons—special devices that help them stand and walk—while doing everyday activities at home. The goal is to see what tasks they can complete and to find small changes in their home environment that could make it easier for them to be more independent. This is an early-stage study, meaning researchers want to test their methods and understand if a larger study is possible in the future.
To participate, you need to be at least 18 years old, speak English, and have received training from the exoskeleton manufacturer to use the device on your own. If you join the study, you will be observed while you go about your daily life at home, helping researchers learn how to improve the experience for exoskeleton users. This trial is currently looking for participants, and it's open to anyone who meets the eligibility criteria, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • English speaking
- • Trained and approved/credentialed by exoskeleton manufacturer to use the device independently according to FDA approved activities
- Exclusion Criteria:
- • Does not speak English
- • \<18 years of age
- • Does not clearly meet inclusion criteria
- • Has not been cleared by manufacturer for independent exoskeleton use
About A.T. Still University Of Health Sciences
A.T. Still University of Health Sciences is a leading institution dedicated to advancing healthcare through innovative education, research, and clinical practice. Founded in 1892, the university emphasizes a holistic approach to health and wellness, integrating traditional and alternative medicine. As a sponsor of clinical trials, A.T. Still University is committed to conducting rigorous research that enhances understanding of medical practices and improves patient outcomes. The university fosters collaboration among diverse disciplines, ensuring that its clinical trials contribute valuable insights to the healthcare community while upholding the highest ethical standards in research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mesa, Arizona, United States
Patients applied
Trial Officials
Sue Dahl-Popolizio, DBH
Principal Investigator
A. T. Still University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported